Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.092492745310153e-58,55.125506072874494,7240.321025807161,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.482250519469672e-55,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.6144155049682595e-28,18.118649318463444,1159.4741477623456,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'ATP5PO', 'SLC25A5']",2.2036771642816742e-26,0,0,44
3,Nonalcoholic fatty liver disease WP4396,9.33749545316202e-16,7.426700958615852,257.0182420510441,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'CYCS']",8.497120862377438e-14,0,0,36
4,Oxidative phosphorylation WP623,5.824097235971058e-15,14.314516129032258,469.1836370116413,"['NDUFB9', 'ATP5PF', 'NDUFB7', 'ATP5PD', 'NDUFA11', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'ATP5PO', 'ATP5MG', 'ATP5MF', 'ATP5ME']",3.9749463635502467e-13,0,0,24
5,Mitochondrial CIV Assembly WP4922,8.312088291941552e-10,14.103174603174603,294.87114980882467,"['COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'SMIM20', 'COX20']",4.538400207400087e-08,0,0,15
6,Mitochondrial complex I assembly model OXPHOS system WP4324,4.961041966714807e-09,8.897836774827926,170.14132095989694,"['NDUFB9', 'NDUFA13', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFS3']",2.2572740948552373e-07,0,0,17
7,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0035001707399595293,27.66839378238342,156.4632043728379,"['GSTP1', 'EPHX2', 'COX5A']",0.11944332650111894,0,0,3
8,Glutathione metabolism WP100,0.0035001707399595293,27.66839378238342,156.4632043728379,"['GPX4', 'IDH1', 'GSS']",0.11944332650111894,0,0,3
9,Mitochondrial complex III assembly WP4921,0.0039650076987399795,6.6031195840554595,36.516885454537196,"['UQCRB', 'UQCRQ', 'UQCR11', 'UQCR10', 'UQCRH']",0.1202719001951127,0,0,5
10,Cellular Proteostasis WP4918,0.015046110142300674,9.219343696027634,38.690227655134656,"['VBP1', 'PFDN4', 'PFDN6']",0.4107588068848084,0,0,3
11,Nanomaterial induced apoptosis WP2507,0.024429646233703278,6.91321243523316,25.661553337966033,"['ENDOG', 'CASP6', 'CYCS']",0.4612327579561116,0,0,3
12,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.024429646233703278,6.91321243523316,25.661553337966033,"['EIF3I', 'EIF2S1', 'EIF3D']",0.4612327579561116,0,0,3
13,Selenium Micronutrient Network WP15,0.025338800323139163,3.080439814814815,11.32190532460766,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SELENOH']",0.4612327579561116,0,0,6
14,One-carbon metabolism and related pathways WP3940,0.02613705546539369,3.551526463138248,12.943187381917905,"['DHFR2', 'GPX4', 'CHKA', 'GSS', 'ETNK1']",0.4612327579561116,0,0,5
15,Apoptosis Modulation by HSP70 WP384,0.0270319565102483,18.413793103448278,66.48733715529613,"['CASP6', 'CYCS']",0.4612327579561116,0,0,2
16,Cytosine methylation WP3585,0.0270319565102483,18.413793103448278,66.48733715529613,"['IDH1', 'TDG']",0.4612327579561116,0,0,2
17,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.03268977194010903,3.2972270363951472,11.278801557262335,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'PIN1']",0.5249592788029274,0,0,5
18,Translation Factors WP107,0.03666502994560787,2.771354166666667,9.161907981443239,"['EEF1B2', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D']",0.5560862875083861,0,0,6
19,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.05803833435355254,2.713834233866857,7.725340427271292,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.8339192251852549,0,0,5
20,Synaptic Vesicle Pathway WP2267,0.06841869819029775,2.562584248026189,6.87313059868692,"['SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'AP2M1']",0.9339152302975643,0,0,5
21,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.07886510487986491,6.135632183908046,15.584606489162192,"['MAP1LC3A', 'ATG7']",0.9360945057479617,0,0,2
22,Kennedy pathway from sphingolipids WP3933,0.07886510487986491,6.135632183908046,15.584606489162192,"['CHKA', 'ETNK1']",0.9360945057479617,0,0,2
23,Nanoparticle triggered autophagic cell death WP2509,0.07886510487986491,6.135632183908046,15.584606489162192,"['MAP1LC3A', 'ATG7']",0.9360945057479617,0,0,2
24,Metapathway biotransformation Phase I and II WP702,0.0919345090705207,1.9581554677206852,4.673488168061042,"['CYP4Z1', 'CYP4X1', 'GPX4', 'GSTO1', 'EPHX2', 'GSTP1', 'GSS']",0.9773553261719065,0,0,7
25,Apoptosis WP254,0.09202904425803904,2.3054592720970537,5.500021340814951,"['IRF3', 'CASP6', 'TRAF3', 'BAD', 'CYCS']",0.9773553261719065,0,0,5
26,Base Excision Repair WP4752,0.09308145963541967,2.633217993079585,6.25199749902314,"['POLE4', 'NEIL2', 'MPG', 'TDG']",0.9773553261719065,0,0,4
27,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.09826076416306902,inf,inf,['TRAF3'],0.9935255043154756,0,0,1
28,Oxidative Damage WP3941,0.10626665316562313,3.0696603339090385,6.881576040977824,"['BAD', 'TRAF3', 'CYCS']",0.996401705921176,0,0,3
29,SARS coronavirus and innate immunity WP4912,0.1107746329081215,4.600862068965517,10.123081162151548,"['IRF3', 'TRAF3']",0.996401705921176,0,0,2
30,Ciliary landscape WP4352,0.11818685219802812,1.5406432748538013,3.2900258631201784,"['MYL6', 'NDUFA5', 'SSNA1', 'TNKS1BP1', 'COPS7A', 'MYL6B', 'SNRPB2', 'WDR34', 'COX6C', 'DCAF11', 'LSM4', 'SPATA7']",0.996401705921176,0,0,12
31,Ferroptosis WP4313,0.1264377297918393,2.3032006920415227,4.763031345484447,"['MAP1LC3A', 'GPX4', 'GSS', 'ATG7']",0.996401705921176,0,0,4
32,SARS-CoV-2 mitochondrial interactions WP5038,0.1285159013945209,2.7621761658031088,5.6671641205904475,"['NDUFB9', 'IRF3', 'TRAF3']",0.996401705921176,0,0,3
33,Apoptosis Modulation and Signaling WP1772,0.13414923062338993,2.003616909049808,4.024870530361725,"['ENDOG', 'CASP6', 'TRAF3', 'BAD', 'CYCS']",0.996401705921176,0,0,5
34,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.1453126496415234,3.68,7.098232964548296,"['IRF3', 'TRAF3']",0.996401705921176,0,0,2
35,Proteasome Degradation WP183,0.14981420420547054,1.9197718082033506,3.6444168411846762,"['PSMC5', 'PSMB5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.996401705921176,0,0,5
36,Regulation of toll-like receptor signaling pathway WP1449,0.15000983028076753,1.784274193548387,3.384865302152964,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'SQSTM1', 'RNF41']",0.996401705921176,0,0,6
37,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.17719456589550253,2.300949913644214,3.981809720029347,"['DEPTOR', 'MAP1LC3A', 'ATG7']",0.996401705921176,0,0,3
38,Parkinson's disease pathway WP2371,0.17719456589550253,2.300949913644214,3.981809720029347,"['CASP6', 'CYCS', 'PARK7']",0.996401705921176,0,0,3
39,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.1816565831572746,3.0660919540229883,5.2296407409465315,"['FGF1', 'GTPBP4']",0.996401705921176,0,0,2
40,Hippo-Yap signaling pathway WP4537,0.1816565831572746,3.0660919540229883,5.2296407409465315,"['NF2', 'STK3']",0.996401705921176,0,0,2
41,MTHFR deficiency WP4288,0.1816565831572746,3.0660919540229883,5.2296407409465315,"['CHKA', 'CYCS']",0.996401705921176,0,0,2
42,Eukaryotic Transcription Initiation WP405,0.1841407434392445,1.9384447277362957,3.2799549072568186,"['TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.996401705921176,0,0,4
43,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.18688141549681703,9.19104991394148,15.415973436740996,['GSS'],0.996401705921176,0,0,1
44,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.18688141549681703,9.19104991394148,15.415973436740996,['ELOB'],0.996401705921176,0,0,1
45,NAD+ metabolism WP3644,0.18688141549681703,9.19104991394148,15.415973436740996,['NAMPT'],0.996401705921176,0,0,1
46,7q11.23 copy number variation syndrome WP4932,0.18745762865314522,1.5737009544008485,2.634693977099153,"['ATP5F1A', 'ATP5F1B', 'ATP5PO', 'SQSTM1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.996401705921176,0,0,7
47,Toll-like Receptor Signaling related to MyD88 WP3858,0.21911967435407134,2.627586206896552,3.989036472477692,"['IRF3', 'TRAF3']",0.996401705921176,0,0,2
48,Hematopoietic Stem Cell Differentiation WP2849,0.21911967435407134,2.627586206896552,3.989036472477692,"['SEC14L2', 'ACVR1B']",0.996401705921176,0,0,2
49,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.21911967435407134,2.627586206896552,3.989036472477692,"['B4GALT2', 'B3GALT2']",0.996401705921176,0,0,2
50,GABA receptor Signaling WP4159,0.2299509769339415,1.971502590673575,2.897890240697023,"['SLC32A1', 'AP2S1', 'AP2M1']",0.996401705921176,0,0,3
51,Autophagy WP4923,0.25713229939899546,2.298706896551724,3.1220222013907066,"['DEPTOR', 'ATG7']",0.996401705921176,0,0,2
52,TLR4 Signaling and Tolerance WP3851,0.25713229939899546,2.298706896551724,3.1220222013907066,"['IRF3', 'TRAF3']",0.996401705921176,0,0,2
53,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.25713229939899546,2.298706896551724,3.1220222013907066,"['IFITM3', 'DDIT3']",0.996401705921176,0,0,2
54,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.25713229939899546,2.298706896551724,3.1220222013907066,"['NF2', 'STK3']",0.996401705921176,0,0,2
55,Oxidation by Cytochrome P450 WP43,0.25713229939899546,2.298706896551724,3.1220222013907066,"['CYP4Z1', 'CYP4X1']",0.996401705921176,0,0,2
56,Cytosolic DNA-sensing pathway WP4655,0.2573248813246232,1.8397236614853194,2.4972700811919517,"['CYLD', 'IRF3', 'POLR2K']",0.996401705921176,0,0,3
57,DNA Repair Pathways Full Network WP4946,0.2605908721913707,1.453673245614035,1.9549050735719264,"['POLE4', 'DCLRE1C', 'NEIL2', 'MPG', 'TDG', 'GTF2H5']",0.996401705921176,0,0,6
58,Caloric restriction and aging WP4191,0.2668061590412011,4.594664371772805,6.070621642136148,['NAMPT'],0.996401705921176,0,0,1
59,Cell Differentiation - Index WP2029,0.2668061590412011,4.594664371772805,6.070621642136148,['LEFTY1'],0.996401705921176,0,0,1
60,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.2668061590412011,4.594664371772805,6.070621642136148,['EPHX2'],0.996401705921176,0,0,1
61,Non-homologous end joining WP438,0.2668061590412011,4.594664371772805,6.070621642136148,['DCLRE1C'],0.996401705921176,0,0,1
62,Modulators of TCR signaling and T cell activation WP5072,0.28510093562959166,1.7244170984455958,2.1639917121027565,"['NDUFB10', 'ELOB', 'RNF7']",0.996401705921176,0,0,3
63,Trans-sulfuration and one-carbon metabolism WP2525,0.29522564190050343,2.042911877394636,2.4923838025844924,"['DHFR2', 'GSS']",0.996401705921176,0,0,2
64,White fat cell differentiation WP4149,0.29522564190050343,2.042911877394636,2.4923838025844924,"['IRF3', 'DDIT3']",0.996401705921176,0,0,2
65,Fas ligand pathway and stress induction of heat shock proteins WP314,0.29522564190050343,2.042911877394636,2.4923838025844924,"['CASP6', 'CYCS']",0.996401705921176,0,0,2
66,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.29522564190050343,2.042911877394636,2.4923838025844924,"['IRF3', 'TRAF3']",0.996401705921176,0,0,2
67,Histone Modifications WP2369,0.33301743475024354,1.8382758620689654,2.021295404276124,"['SET', 'SETDB2']",0.996401705921176,0,0,2
68,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.33301743475024354,1.8382758620689654,2.021295404276124,"['RAB4A', 'RABAC1']",0.996401705921176,0,0,2
69,Pyrimidine metabolism WP4022,0.33631846923785896,1.3525843613008461,1.4739067728837179,"['POLE4', 'POLR1B', 'NME3', 'POLR2I', 'POLR2K']",0.996401705921176,0,0,5
70,Acetylcholine Synthesis WP528,0.33888694060149976,3.0625358577165804,3.3139355545518776,['CHKA'],0.996401705921176,0,0,1
71,Dual hijack model of Vif in HIV infection WP3300,0.33888694060149976,3.0625358577165804,3.3139355545518776,['ELOB'],0.996401705921176,0,0,1
72,Glial Cell Differentiation WP2276,0.33888694060149976,3.0625358577165804,3.3139355545518776,['MBP'],0.996401705921176,0,0,1
73,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.33888694060149976,3.0625358577165804,3.3139355545518776,['SQSTM1'],0.996401705921176,0,0,1
74,Alzheimer's disease WP2059,0.36341087279623396,1.3620402409329746,1.3786860123424085,"['ATP5MD', 'APH1A', 'BAD', 'CYCS']",0.996401705921176,0,0,4
75,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.369129377361504,1.4513226070357241,1.4463998372027989,"['BEX3', 'RNF7', 'SQSTM1']",0.996401705921176,0,0,3
76,Exercise-induced Circadian Regulation WP410,0.369129377361504,1.4513226070357241,1.4463998372027989,"['DAZAP2', 'SUMO1', 'GSTP1']",0.996401705921176,0,0,3
77,Type 2 papillary renal cell carcinoma WP4241,0.37019952365733994,1.670846394984326,1.6603420603254577,"['COL21A1', 'ELOB']",0.996401705921176,0,0,2
78,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.37019952365733994,1.670846394984326,1.6603420603254577,"['IRF3', 'TRAF3']",0.996401705921176,0,0,2
79,mRNA Processing WP411,0.39243170085033385,1.191916264090177,1.1149098528641859,"['LSM7', 'SF3A1', 'CELF1', 'HNRNPA2B1', 'SNRPG', 'SNRPB2', 'DNAJC8']",0.996401705921176,0,0,7
80,VEGFA-VEGFR2 Signaling Pathway WP3888,0.39528863135456377,1.0969423700154994,1.0181150696483139,"['RPL5', 'RAB4A', 'SET', 'TRPC3', 'RPS6', 'RPL10A', 'PDIA6', 'RPL7', 'RCN1', 'RPL18A', 'AP2S1', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'CCT7', 'EIF3D', 'PTMA']",0.996401705921176,0,0,18
81,DNA IR-double strand breaks and cellular response via ATM WP3959,0.3968776647351515,1.3784974093264248,1.2739069442844075,"['DCLRE1C', 'TRIM28', 'STK3']",0.996401705921176,0,0,3
82,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.40389238175334063,2.2964716006884682,2.0819968112292995,['IRF3'],0.996401705921176,0,0,1
83,Transcription co-factors SKI and SKIL protein partners WP4533,0.40389238175334063,2.2964716006884682,2.0819968112292995,['STK3'],0.996401705921176,0,0,1
84,Transcriptional cascade regulating adipogenesis WP4211,0.40389238175334063,2.2964716006884682,2.0819968112292995,['DDIT3'],0.996401705921176,0,0,1
85,Insulin signaling in adipocytes (diabetic condition) WP3635,0.40389238175334063,2.2964716006884682,2.0819968112292995,['RPS6'],0.996401705921176,0,0,1
86,Insulin signaling in adipocytes (normal condition) WP3634,0.40389238175334063,2.2964716006884682,2.0819968112292995,['RPS6'],0.996401705921176,0,0,1
87,"NAD metabolism, sirtuins and aging WP3630",0.40389238175334063,2.2964716006884682,2.0819968112292995,['NAMPT'],0.996401705921176,0,0,1
88,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.40389238175334063,2.2964716006884682,2.0819968112292995,['IRF3'],0.996401705921176,0,0,1
89,Amyotrophic lateral sclerosis (ALS) WP2447,0.4065270326351814,1.5313218390804597,1.3783502161933472,"['TOMM40', 'BAD']",0.996401705921176,0,0,2
90,Unfolded protein response WP4925,0.4065270326351814,1.5313218390804597,1.3783502161933472,"['DDIT3', 'EIF2S1']",0.996401705921176,0,0,2
91,Differentiation Pathway WP2848,0.4065270326351814,1.5313218390804597,1.3783502161933472,"['LEFTY1', 'FGF1']",0.996401705921176,0,0,2
92,NO/cGMP/PKG mediated Neuroprotection WP4008,0.4065270326351814,1.5313218390804597,1.3783502161933472,"['BAD', 'CYCS']",0.996401705921176,0,0,2
93,Complement system WP2806,0.4418089375526467,1.413262599469496,1.1544627841998554,"['RPS19', 'CD59']",0.996401705921176,0,0,2
94,Acute viral myocarditis WP4298,0.45125166464273314,1.2527084314649082,0.9968177808658893,"['ENDOG', 'CASP6', 'CYCS']",0.996401705921176,0,0,3
95,Serotonin and anxiety-related events WP3944,0.46251590731676595,1.8368330464716007,1.4163348077327322,['CRH'],0.996401705921176,0,0,1
96,Thiamine metabolic pathways WP4297,0.46251590731676595,1.8368330464716007,1.4163348077327322,['BCKDK'],0.996401705921176,0,0,1
97,CAMKK2  Pathway WP4874,0.4758998768017917,1.3120689655172413,0.9742739103171796,"['MAP1LC3A', 'SQSTM1']",0.996401705921176,0,0,2
98,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.508693046757045,1.224367816091954,0.827563057736522,"['DEPTOR', 'MAP1LC3A']",0.996401705921176,0,0,2
99,Photodynamic therapy-induced unfolded protein response WP3613,0.508693046757045,1.224367816091954,0.827563057736522,"['DDIT3', 'PDIA6']",0.996401705921176,0,0,2
100,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5153830887904024,1.5304073436603558,1.014422539094015,['SST'],0.996401705921176,0,0,1
101,Cell Differentiation - Index expanded WP2023,0.5153830887904024,1.5304073436603558,1.014422539094015,['LEFTY1'],0.996401705921176,0,0,1
102,Tryptophan catabolism leading to NAD+ production WP4210,0.5153830887904024,1.5304073436603558,1.014422539094015,['NAMPT'],0.996401705921176,0,0,1
103,Type II diabetes mellitus WP1584,0.5153830887904024,1.5304073436603558,1.014422539094015,['SURF1'],0.996401705921176,0,0,1
104,Urea cycle and metabolism of amino groups WP497,0.5153830887904024,1.5304073436603558,1.014422539094015,['ODC1'],0.996401705921176,0,0,1
105,Cysteine and methionine catabolism WP4504,0.5153830887904024,1.5304073436603558,1.014422539094015,['GSS'],0.996401705921176,0,0,1
106,Glycerolipids and Glycerophospholipids WP4722,0.5153830887904024,1.5304073436603558,1.014422539094015,['ETNK1'],0.996401705921176,0,0,1
107,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5153830887904024,1.5304073436603558,1.014422539094015,['BAD'],0.996401705921176,0,0,1
108,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5153830887904024,1.5304073436603558,1.014422539094015,['EIF2AK1'],0.996401705921176,0,0,1
109,miRNAs involvement in the immune response in sepsis WP4329,0.5153830887904024,1.5304073436603558,1.014422539094015,['TRAF3'],0.996401705921176,0,0,1
110,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5153830887904024,1.5304073436603558,1.014422539094015,['NAMPT'],0.996401705921176,0,0,1
111,NAD+ biosynthetic pathways WP3645,0.5153830887904024,1.5304073436603558,1.014422539094015,['NAMPT'],0.996401705921176,0,0,1
112,Oxidative Stress WP408,0.5153830887904024,1.5304073436603558,1.014422539094015,['TXN2'],0.996401705921176,0,0,1
113,Senescence and Autophagy in Cancer WP615,0.5212356507217774,1.0801953999592917,0.7038045910629916,"['GABARAPL1', 'MAP1LC3A', 'SQSTM1', 'ATG7']",0.996401705921176,0,0,4
114,ATM Signaling Network in Development and Disease  WP3878,0.5401140493129065,1.1476293103448276,0.7069109177226524,"['DCLRE1C', 'TRIM28']",0.996401705921176,0,0,2
115,Development of ureteric collection system WP5053,0.5401140493129065,1.1476293103448276,0.7069109177226524,"['GDF11', 'FAT4']",0.996401705921176,0,0,2
116,Kit receptor signaling pathway WP304,0.5401140493129065,1.1476293103448276,0.7069109177226524,"['BAD', 'RPS6']",0.996401705921176,0,0,2
117,Ebola Virus Pathway on Host WP4217,0.5423690313754863,1.049134948096886,0.6418698252812961,"['IRF3', 'HLA-B', 'DAB2IP', 'EIF2S1']",0.996401705921176,0,0,4
118,MECP2 and Associated Rett Syndrome WP3584,0.5530852487793992,1.0591869270625747,0.6272961834976032,"['SST', 'RPS6', 'MBP']",0.996401705921176,0,0,3
119,Serotonin and anxiety WP3947,0.5630582732012459,1.3115318416523236,0.7533073655204311,['CRH'],0.996401705921176,0,0,1
120,Sleep regulation WP3591,0.5630582732012459,1.3115318416523236,0.7533073655204311,['CRH'],0.996401705921176,0,0,1
121,Cell migration and invasion through p75NTR WP4561,0.5630582732012459,1.3115318416523236,0.7533073655204311,['CDH11'],0.996401705921176,0,0,1
122,Type II interferon signaling (IFNG) WP619,0.5630582732012459,1.3115318416523236,0.7533073655204311,['HLA-B'],0.996401705921176,0,0,1
123,DNA Mismatch Repair WP531,0.5630582732012459,1.3115318416523236,0.7533073655204311,['POLE4'],0.996401705921176,0,0,1
124,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5630582732012459,1.3115318416523236,0.7533073655204311,['RPS6'],0.996401705921176,0,0,1
125,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5630582732012459,1.3115318416523236,0.7533073655204311,['SHISA5'],0.996401705921176,0,0,1
126,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5630582732012459,1.3115318416523236,0.7533073655204311,['STK3'],0.996401705921176,0,0,1
127,Pregnane X receptor pathway WP2876,0.5630582732012459,1.3115318416523236,0.7533073655204311,['PSMC5'],0.996401705921176,0,0,1
128,Nephrotic syndrome WP4758,0.5701155726731434,1.0799188640973632,0.6068238824247092,"['COL4A4', 'ZMPSTE24']",0.996401705921176,0,0,2
129,Regulation of Microtubule Cytoskeleton WP2038,0.5701155726731434,1.0799188640973632,0.6068238824247092,"['PARD6A', 'MAPRE1']",0.996401705921176,0,0,2
130,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5767428416778143,1.0197658798695068,0.5612371192843915,"['BAD', 'RPS6', 'PDGFC']",0.996401705921176,0,0,3
131,MET in type 1 papillary renal cell carcinoma WP4205,0.5986728021994865,1.0197318007662834,0.5231632746276477,"['BAD', 'RPL11']",0.996401705921176,0,0,2
132,Nucleotide Excision Repair WP4753,0.5986728021994865,1.0197318007662834,0.5231632746276477,"['POLE4', 'GTF2H5']",0.996401705921176,0,0,2
133,RANKL/RANK signaling pathway WP2018,0.5986728021994865,1.0197318007662834,0.5231632746276477,"['TRAF3', 'SQSTM1']",0.996401705921176,0,0,2
134,Regulatory circuits of the STAT3 signaling pathway WP4538,0.5986728021994865,1.0197318007662834,0.5231632746276477,"['DEPTOR', 'TRIM28']",0.996401705921176,0,0,2
135,16p11.2 distal deletion syndrome WP4950,0.6060505655852146,1.1473752151462995,0.574596162183808,['RAB4A'],0.996401705921176,0,0,1
136,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6060505655852146,1.1473752151462995,0.574596162183808,['RPS6'],0.996401705921176,0,0,1
137,Gastric Cancer Network 2 WP2363,0.6060505655852146,1.1473752151462995,0.574596162183808,['OTUD5'],0.996401705921176,0,0,1
138,GDNF/RET signaling axis WP4830,0.6060505655852146,1.1473752151462995,0.574596162183808,['FAT4'],0.996401705921176,0,0,1
139,IL-7 signaling pathway WP205,0.6060505655852146,1.1473752151462995,0.574596162183808,['BAD'],0.996401705921176,0,0,1
140,Nanoparticle-mediated activation of receptor signaling WP2643,0.6060505655852146,1.1473752151462995,0.574596162183808,['TLN1'],0.996401705921176,0,0,1
141,Neural Crest Cell Migration during Development WP4564,0.6060505655852146,1.1473752151462995,0.574596162183808,['CDH11'],0.996401705921176,0,0,1
142,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6060505655852146,1.1473752151462995,0.574596162183808,['MBP'],0.996401705921176,0,0,1
143,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6060505655852146,1.1473752151462995,0.574596162183808,['GSTP1'],0.996401705921176,0,0,1
144,16p11.2 proximal deletion syndrome WP4949,0.6216321109974439,0.9490798642129712,0.4511990426810427,"['TMEM219', 'SEZ6L2', 'CCT7']",0.996401705921176,0,0,3
145,Amino Acid metabolism WP3925,0.6216321109974439,0.9490798642129712,0.4511990426810427,"['IDH1', 'GSS', 'ODC1']",0.996401705921176,0,0,3
146,Adipogenesis WP236,0.6217381368727262,0.9408215774997782,0.4471125435313689,"['CELF1', 'DDIT3', 'NAMPT', 'ZMPSTE24']",0.996401705921176,0,0,4
147,TP53 network WP1742,0.6448192280336387,1.0196978389749474,0.4474283896381818,['SUMO1'],0.996401705921176,0,0,1
148,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6448192280336387,1.0196978389749474,0.4474283896381818,['H2AFZ'],0.996401705921176,0,0,1
149,Neural Crest Cell Migration in Cancer WP4565,0.6448192280336387,1.0196978389749474,0.4474283896381818,['CDH11'],0.996401705921176,0,0,1
150,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6448192280336387,1.0196978389749474,0.4474283896381818,['BAD'],0.996401705921176,0,0,1
151,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6448192280336387,1.0196978389749474,0.4474283896381818,['TRPC3'],0.996401705921176,0,0,1
152,Proximal tubule transport WP4917,0.6514444558103168,0.9174137931034483,0.3931697376011914,"['SLC47A1', 'ATP6V1F']",0.996401705921176,0,0,2
153,Small cell lung cancer WP4658,0.6631643176985726,0.8875146247701822,0.36453108272384216,"['TRAF3', 'COL4A4', 'CYCS']",0.996401705921176,0,0,3
154,IL-18 signaling pathway WP4754,0.6701404108872212,0.8908937198067632,0.3565962653155239,"['TOMM40', 'NACA', 'BAD', 'CYCS', 'NDUFC1', 'RND2', 'AARS']",0.996401705921176,0,0,7
155,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.675688889042371,0.8735632183908046,0.3424564648968277,"['BAD', 'CYCS']",0.996401705921176,0,0,2
156,Endometrial cancer WP4155,0.675688889042371,0.8735632183908046,0.3424564648968277,"['BAD', 'FGF1']",0.996401705921176,0,0,2
157,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.675688889042371,0.8735632183908046,0.3424564648968277,"['COL4A4', 'TLN1']",0.996401705921176,0,0,2
158,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6797785519656624,0.9175559380378657,0.35416575824675617,['IDH1'],0.996401705921176,0,0,1
159,BDNF-TrkB Signaling WP3676,0.6797785519656624,0.9175559380378657,0.35416575824675617,['TRPC3'],0.996401705921176,0,0,1
160,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6797785519656624,0.9175559380378657,0.35416575824675617,['TRAF3'],0.996401705921176,0,0,1
161,Fatty acid beta-oxidation WP143,0.6797785519656624,0.9175559380378657,0.35416575824675617,['CPT1B'],0.996401705921176,0,0,1
162,Fluoropyrimidine Activity WP1601,0.6797785519656624,0.9175559380378657,0.35416575824675617,['TDG'],0.996401705921176,0,0,1
163,IL17 signaling pathway WP2112,0.6797785519656624,0.9175559380378657,0.35416575824675617,['TRAF3'],0.996401705921176,0,0,1
164,Methionine De Novo and Salvage Pathway WP3580,0.6797785519656624,0.9175559380378657,0.35416575824675617,['ODC1'],0.996401705921176,0,0,1
165,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6797785519656624,0.9175559380378657,0.35416575824675617,['NDUFA13'],0.996401705921176,0,0,1
166,EGF/EGFR signaling pathway WP437,0.6918573368146839,0.8526595316649231,0.31409888581818723,"['NDUFA13', 'AP2S1', 'NEDD8', 'AP2M1']",0.996401705921176,0,0,4
167,Toll-like Receptor Signaling Pathway WP75,0.6985436543405424,0.8336990595611286,0.29909587787526554,"['IRF3', 'TRAF3']",0.996401705921176,0,0,2
168,Pathways Regulating Hippo Signaling WP4540,0.7012875976134916,0.8334118385931858,0.2957255302933937,"['CDH11', 'NF2', 'STK3']",0.996401705921176,0,0,3
169,7-oxo-C and 7beta-HC pathways WP5064,0.7113022543936215,0.8339852918166171,0.2841036179678725,['EPHX2'],0.996401705921176,0,0,1
170,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7113022543936215,0.8339852918166171,0.2841036179678725,['IRF3'],0.996401705921176,0,0,1
171,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7113022543936215,0.8339852918166171,0.2841036179678725,['RPS6'],0.996401705921176,0,0,1
172,Intraflagellar transport proteins binding to dynein WP4532,0.7113022543936215,0.8339852918166171,0.2841036179678725,['WDR34'],0.996401705921176,0,0,1
173,miRNA regulation of prostate cancer signaling pathways WP3981,0.7113022543936215,0.8339852918166171,0.2841036179678725,['BAD'],0.996401705921176,0,0,1
174,Notch Signaling WP268,0.7113022543936215,0.8339852918166171,0.2841036179678725,['APH1A'],0.996401705921176,0,0,1
175,Pre-implantation embryo WP3527,0.7113022543936215,0.8339852918166171,0.2841036179678725,['DDIT3'],0.996401705921176,0,0,1
176,3q29 copy number variation syndrome WP4906,0.7200472812607316,0.7973013493253374,0.2618643800566812,"['NF2', 'WDR34']",0.996401705921176,0,0,2
177,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7200472812607316,0.7973013493253374,0.2618643800566812,"['BAD', 'RPS6']",0.996401705921176,0,0,2
178,"GPCRs, Class A Rhodopsin-like WP455",0.7360370560027952,0.7854922279792746,0.24073358422550817,"['MC1R', 'HTR5A', 'MCHR1']",0.996401705921176,0,0,3
179,Hippo-Merlin Signaling Dysregulation WP4541,0.7360370560027952,0.7854922279792746,0.24073358422550817,"['CDH11', 'NF2', 'STK3']",0.996401705921176,0,0,3
180,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7380434520543091,0.7965999699112382,0.2419692944893209,"['BAD', 'RPS6', 'SQSTM1', 'EIF2S1']",0.996401705921176,0,0,4
181,Allograft Rejection WP2328,0.7397274458638649,0.7643430866322433,0.23042916797029095,['HLA-B'],0.996401705921176,0,0,1
182,Splicing factor NOVA regulated synaptic proteins WP4148,0.7397274458638649,0.7643430866322433,0.23042916797029095,['NTNG1'],0.996401705921176,0,0,1
183,DNA Replication WP466,0.7397274458638649,0.7643430866322433,0.23042916797029095,['UBA52'],0.996401705921176,0,0,1
184,IL-2 signaling pathway WP49,0.7397274458638649,0.7643430866322433,0.23042916797029095,['RPS6'],0.996401705921176,0,0,1
185,MAPK Cascade WP422,0.7397274458638649,0.7643430866322433,0.23042916797029095,['MBP'],0.996401705921176,0,0,1
186,Oxysterols derived from cholesterol WP4545,0.7397274458638649,0.7643430866322433,0.23042916797029095,['EPHX2'],0.996401705921176,0,0,1
187,Peptide GPCRs WP24,0.7397274458638649,0.7643430866322433,0.23042916797029095,['MC1R'],0.996401705921176,0,0,1
188,22q11.2 copy number variation syndrome WP4657,0.7402441477365974,0.7639367816091954,0.229773251892935,"['RANBP1', 'MRPL40']",0.996401705921176,0,0,2
189,Non-small cell lung cancer WP4255,0.7402441477365974,0.7639367816091954,0.229773251892935,"['BAD', 'CYCS']",0.996401705921176,0,0,2
190,Integrated breast cancer pathway WP1984,0.7522239576942285,0.779503791504086,0.2219412418944894,"['FER', 'BAD', 'ODC1', 'FAU']",0.996401705921176,0,0,4
191,Corticotropin-releasing hormone signaling pathway WP2355,0.7591829630267447,0.7332413793103448,0.20201714544847518,"['TRIM28', 'CRH']",0.996401705921176,0,0,2
192,Head and Neck Squamous Cell Carcinoma WP4674,0.7591829630267447,0.7332413793103448,0.20201714544847518,"['TRAF3', 'RPS6']",0.996401705921176,0,0,2
193,The influence of laminopathies on Wnt signaling WP4844,0.7653582103531691,0.70541506686085,0.1886359642464568,['ZMPSTE24'],0.996401705921176,0,0,1
194,Folate Metabolism WP176,0.7653582103531691,0.70541506686085,0.1886359642464568,['GPX4'],0.996401705921176,0,0,1
195,Integrated Cancer Pathway WP1971,0.7653582103531691,0.70541506686085,0.1886359642464568,['BAD'],0.996401705921176,0,0,1
196,Interleukin-11 Signaling Pathway WP2332,0.7653582103531691,0.70541506686085,0.1886359642464568,['RPS6'],0.996401705921176,0,0,1
197,Lung fibrosis WP3624,0.7653582103531691,0.70541506686085,0.1886359642464568,['FGF1'],0.996401705921176,0,0,1
198,Monoamine GPCRs WP58,0.7653582103531691,0.70541506686085,0.1886359642464568,['HTR5A'],0.996401705921176,0,0,1
199,Fragile X Syndrome  WP4549,0.7658076707863584,0.7631199538638985,0.20361888896864883,"['DEPTOR', 'ALDH5A1', 'AP2S1', 'AP2M1']",0.996401705921176,0,0,4
200,Hepatitis B infection WP4666,0.7658076707863584,0.7631199538638985,0.20361888896864883,"['IRF3', 'TRAF3', 'BAD', 'CYCS']",0.996401705921176,0,0,4
201,TNF-alpha signaling pathway WP231,0.7769154911960829,0.7049071618037135,0.17793527215487992,"['BAD', 'KSR2']",0.996401705921176,0,0,2
202,Copper homeostasis WP3286,0.7884688357433782,0.6549053356282272,0.15564637176267415,['ATOX1'],0.996401705921176,0,0,1
203,Vitamin D-sensitive calcium signaling in depression WP4698,0.7884688357433782,0.6549053356282272,0.15564637176267415,['GPX4'],0.996401705921176,0,0,1
204,G13 Signaling Pathway WP524,0.7884688357433782,0.6549053356282272,0.15564637176267415,['ARHGDIG'],0.996401705921176,0,0,1
205,Genotoxicity pathway WP4286,0.7884688357433782,0.6549053356282272,0.15564637176267415,['RPS27'],0.996401705921176,0,0,1
206,Glycogen Synthesis and Degradation WP500,0.7884688357433782,0.6549053356282272,0.15564637176267415,['PHKG1'],0.996401705921176,0,0,1
207,IL-5 signaling pathway WP127,0.7884688357433782,0.6549053356282272,0.15564637176267415,['RPS6'],0.996401705921176,0,0,1
208,Leptin signaling pathway WP2034,0.7934954831780905,0.6786717752234993,0.15698182502887548,"['BAD', 'RPS6']",0.996401705921176,0,0,2
209,Mesodermal commitment pathway WP2857,0.7958649745418752,0.7043975023249635,0.16083207921084564,"['LEFTY1', 'TRIM28', 'RPL38']",0.996401705921176,0,0,3
210,IL-3 signaling pathway WP286,0.8093067291896935,0.6111302352266208,0.12930127759325488,['BAD'],0.996401705921176,0,0,1
211,Pathogenic Escherichia coli infection WP2272,0.8093067291896935,0.6111302352266208,0.12930127759325488,['ARPC3'],0.996401705921176,0,0,1
212,TGF-beta Receptor Signaling WP560,0.8280950469938086,0.5728270223752151,0.10805083758496242,['LEFTY1'],0.996401705921176,0,0,1
213,IL-6 signaling pathway WP364,0.8280950469938086,0.5728270223752151,0.10805083758496242,['BAD'],0.996401705921176,0,0,1
214,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8450350682428023,0.539030069859269,0.09076034779345016,['ZMPSTE24'],0.996401705921176,0,0,1
215,Interferon type I signaling pathways WP585,0.8450350682428023,0.539030069859269,0.09076034779345016,['RPS6'],0.996401705921176,0,0,1
216,p38 MAPK Signaling Pathway WP400,0.8450350682428023,0.539030069859269,0.09076034779345016,['DDIT3'],0.996401705921176,0,0,1
217,Circadian rhythm related genes WP3594,0.8451337936817332,0.6651148159798679,0.11191243738755662,"['NAMPT', 'CRH', 'RPS27A', 'UBA52']",0.996401705921176,0,0,4
218,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8603083360907544,0.5089883342895392,0.07658463636504756,['MBP'],0.996401705921176,0,0,1
219,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8603083360907544,0.5089883342895392,0.07658463636504756,['LEFTY1'],0.996401705921176,0,0,1
220,Notch Signaling Pathway Netpath WP61,0.8603083360907544,0.5089883342895392,0.07658463636504756,['APH1A'],0.996401705921176,0,0,1
221,PPAR signaling pathway WP3942,0.8603083360907544,0.5089883342895392,0.07658463636504756,['CPT1B'],0.996401705921176,0,0,1
222,Rett syndrome causing genes WP4312,0.8603083360907544,0.5089883342895392,0.07658463636504756,['GPS2'],0.996401705921176,0,0,1
223,Thermogenesis WP4321,0.8610280893334774,0.5720905172413793,0.08560084630281717,"['RPS6', 'CPT1B']",0.996401705921176,0,0,2
224,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.874078589991751,0.4821088866745176,0.06488461847232574,['RPS6'],0.996401705921176,0,0,1
225,"GPCRs, Other WP117",0.874078589991751,0.4821088866745176,0.06488461847232574,['CELSR2'],0.996401705921176,0,0,1
226,IL-4 signaling pathway WP395,0.874078589991751,0.4821088866745176,0.06488461847232574,['BAD'],0.996401705921176,0,0,1
227,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8864935088056772,0.4579173838209983,0.055170562182072835,['BAD'],0.996401705921176,0,0,1
228,Androgen receptor signaling pathway WP138,0.8911735280558141,0.5227586206896552,0.06023021681382822,"['SUMO1', 'PARK7']",0.996401705921176,0,0,2
229,Focal Adhesion WP306,0.8938750068414759,0.5990129899597254,0.06720286418378855,"['BAD', 'COL4A4', 'PDGFC', 'TLN1']",0.996401705921176,0,0,4
230,IL-1 signaling pathway WP195,0.8976862837527743,0.43602983362019504,0.04706271512342932,['SQSTM1'],0.996401705921176,0,0,1
231,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8976862837527743,0.43602983362019504,0.04706271512342932,['IFI27L2'],0.996401705921176,0,0,1
232,MAPK Signaling Pathway WP382,0.8996557202464613,0.6167736193732728,0.06521956801917077,"['DUSP4', 'DDIT3', 'RASGRF2', 'FGF1', 'STK3']",0.996401705921176,0,0,5
233,TGF-beta Signaling Pathway WP366,0.90777141951083,0.49431500465983225,0.047831241006436924,"['PARD6A', 'SUMO1']",0.996401705921176,0,0,2
234,AGE/RAGE pathway WP2324,0.9077770376852604,0.41613206071037395,0.040263474967495126,['CYCS'],0.996401705921176,0,0,1
235,DNA damage response WP707,0.9077770376852604,0.41613206071037395,0.040263474967495126,['CYCS'],0.996401705921176,0,0,1
236,Prolactin Signaling Pathway WP2037,0.9077770376852604,0.41613206071037395,0.040263474967495126,['RPS6'],0.996401705921176,0,0,1
237,Ectoderm Differentiation WP2858,0.9113905735265557,0.5374377730366758,0.04986548824191218,"['ARHGDIG', 'NF2', 'CELSR2']",0.996401705921176,0,0,3
238,Pathways in clear cell renal cell carcinoma WP4018,0.9151533922661395,0.48121597096188745,0.0426663335951637,"['DEPTOR', 'SQSTM1']",0.996401705921176,0,0,2
239,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9168741048149206,0.397964528923146,0.03453739399756701,['RPS6'],0.996401705921176,0,0,1
240,miRNA regulation of DNA damage response WP1530,0.9168741048149206,0.397964528923146,0.03453739399756701,['CYCS'],0.996401705921176,0,0,1
241,Neural Crest Differentiation WP2064,0.9168741048149206,0.397964528923146,0.03453739399756701,['MBP'],0.996401705921176,0,0,1
242,Oncostatin M Signaling Pathway WP2374,0.9168741048149206,0.397964528923146,0.03453739399756701,['RPS6'],0.996401705921176,0,0,1
243,Endoderm differentiation WP2853,0.9282838357034885,0.45698275862068966,0.034007622069003894,"['DUSP4', 'TCEAL2']",0.996401705921176,0,0,2
244,Gastrin signaling pathway WP4659,0.9282838357034885,0.45698275862068966,0.034007622069003894,"['BAD', 'RPS6']",0.996401705921176,0,0,2
245,ErbB signaling pathway WP673,0.9324683921143582,0.3659896729776248,0.02559000667975777,['BAD'],0.996401705921176,0,0,1
246,Ras signaling WP4223,0.9388132981080969,0.4889896373056995,0.030874145611928923,"['BAD', 'RASGRF2', 'KSR2']",0.996401705921176,0,0,3
247,Retinoblastoma gene in cancer WP2446,0.9391331810213482,0.3518469482324904,0.02209527656530205,['H2AFZ'],0.996401705921176,0,0,1
248,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9445375709456749,0.5691189236111112,0.0324738200220746,"['PIK3IP1', 'BAD', 'COL4A4', 'PDGFC', 'RPS6', 'FGF1']",0.996401705921176,0,0,6
249,NRF2 pathway WP2884,0.9490028863071703,0.4151253918495298,0.02172909060788698,"['GSTP1', 'SQSTM1']",0.996401705921176,0,0,2
250,AMP-activated protein kinase (AMPK) signaling WP1403,0.9505570932054077,0.326592082616179,0.016560521833764004,['CPT1B'],0.996401705921176,0,0,1
251,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9505570932054077,0.326592082616179,0.016560521833764004,['SLC38A2'],0.996401705921176,0,0,1
252,Endochondral Ossification WP474,0.9505570932054077,0.326592082616179,0.016560521833764004,['SLC38A2'],0.996401705921176,0,0,1
253,Melanoma WP4685,0.9505570932054077,0.326592082616179,0.016560521833764004,['BAD'],0.996401705921176,0,0,1
254,DNA IR-damage and cellular response via ATR WP4016,0.9598397871487672,0.30470453241537576,0.012489502644139512,['TRIM28'],0.996401705921176,0,0,1
255,Pancreatic adenocarcinoma pathway WP4263,0.9598397871487672,0.30470453241537576,0.012489502644139512,['BAD'],0.996401705921176,0,0,1
256,Spinal Cord Injury WP2431,0.9638065229151277,0.29481983232469045,0.010868446702595557,['MBP'],0.996401705921176,0,0,1
257,Myometrial relaxation and contraction pathways WP289,0.96689673634229,0.4272182642487047,0.014381694883595602,"['GRK4', 'GSTO1', 'CRH']",0.996401705921176,0,0,3
258,Integrin-mediated Cell Adhesion WP185,0.9673820361644365,0.28555292598967297,0.00946944558213055,['TLN1'],0.996401705921176,0,0,1
259,Osteoblast differentiation WP4787,0.9673820361644365,0.28555292598967297,0.00946944558213055,['FGF1'],0.996401705921176,0,0,1
260,PI3K-Akt signaling pathway WP4172,0.9682251050305208,0.4944050938135785,0.01596467282881481,"['BAD', 'COL4A4', 'PDGFC', 'RPS6', 'FGF1']",0.996401705921176,0,0,5
261,ESC Pluripotency Pathways WP3931,0.9706048514021621,0.27684765034162623,0.00825998321593043,['FGF1'],0.996401705921176,0,0,1
262,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9706048514021621,0.27684765034162623,0.00825998321593043,['PSMC5'],0.996401705921176,0,0,1
263,DNA damage response (only ATM dependent) WP710,0.978487733740407,0.25363358194683494,0.0055157766092049565,['BAD'],0.996401705921176,0,0,1
264,Genes related to primary cilium development (based on CRISPR) WP4536,0.978487733740407,0.25363358194683494,0.0055157766092049565,['WDR34'],0.996401705921176,0,0,1
265,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9872193185160876,0.22249275849040762,0.002861937039712451,['COL4A4'],0.996401705921176,0,0,1
266,Breast cancer pathway WP4262,0.9906504969997616,0.2072054451572524,0.0019463810237328489,['FGF1'],0.996401705921176,0,0,1
267,Chemokine signaling pathway WP3929,0.9906504969997616,0.2072054451572524,0.0019463810237328489,['GRK4'],0.996401705921176,0,0,1
268,Regulation of Actin Cytoskeleton WP51,0.9906504969997616,0.2072054451572524,0.0019463810237328489,['FGF1'],0.996401705921176,0,0,1
269,Calcium Regulation in the Cardiac Cell WP536,0.9913652111267811,0.28432112068965515,0.0024657136946616854,"['GRK4', 'ATP1B2']",0.996401705921176,0,0,2
270,Ciliopathies WP4803,0.9921180685863298,0.279893899204244,0.00221484465528693,"['WDR34', 'SPATA7']",0.996401705921176,0,0,2
271,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9949987283019204,0.1821342512908778,0.0009131883359402889,['SST'],0.996401705921176,0,0,1
272,Insulin Signaling WP481,0.995940573382914,0.1750628889183106,0.0007121012922887108,['RAB4A'],0.996401705921176,0,0,1
273,Nuclear Receptors Meta-Pathway WP2882,0.996401705921176,0.29892387405340776,0.0010775558522009994,"['PSMC5', 'GSTP1', 'SQSTM1']",0.996401705921176,0,0,3
